O-5 | Two-Year Outcomes in an Expanded Cohort of Harmony Transcatheter Pulmonary Valve Recipients
Bibliographic record
Abstract
The Harmony transcatheter pulmonary valve (TPV) is the first FDA-approved device for severe pulmonary regurgitation (PR) in the native or surgically repaired right ventricular outflow tract (RVOT). Our objective was to evaluate 2-year safety and effectiveness in patients from an expanded cohort of Harmony clinical trial participants. The analysis included patients who received a commercially available TPV22 or TPV25 device as part of the Harmony Native Outflow Tract Early Feasibility Study (EFS), Harmony TPV Pivotal Trial, and Continued Access Study (CAS). Eligible patients had severe PR by echocardiography or PR fraction ≥30% by cardiac magnetic resonance imaging and a clinical indication for pulmonary valve replacement. One-year outcomes are reported here, and 2-year outcomes by valve type will be presented. Eighty-seven patients were implanted with a TPV22 (n=42) or TPV25 (n=45) device, all of whom remained implanted for >24 hours. Median (Q1, Q3) patient age at treatment was 29 (18, 39) years and 87% had an original diagnosis of tetralogy of Fallot. At 1 year, all patients were alive, and freedom from the composite of PR, stenosis, and reintervention (defined as ≥moderate PR, mean RVOT gradient >40 mmHg, device-related RVOT reoperation, and catheter reintervention) was 98% in the TPV22 group and 91% in the TPV25 group. One-year freedom from major stent fracture was 98% in the TPV22 group and 100% in the TPV25 group. None/trace or mild PR was present in 98% of TPV22 and 100% of TPV25 patients at 1 year. Two TPV22 patients from the EFS were explanted on Day 2 and Day 39, respectively. Two TPV25 patients from the CAS underwent valve-in-valve procedures on Day 0 and Day 303, respectively. Fourteen (3 TPV22, 11 TPV25) patients had nonsustained ventricular tachycardia (NSVT), which initiated during the implant procedure in 13 patients and at 1-day postimplant in 1 patient. There were no serious adverse events related to the NSVT. Harmony TPV patients in this expanded analysis cohort had favorable clinical and hemodynamic outcomes across studies and valve types through 1 year, and the upcoming 2-year analysis will expand our understanding of this patient population.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.298 |
| Bibliometrics | 0.000 | 0.001 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".